Stockreport

Citius Oncology Announces Closing of $9.0 Million Registered Direct Offering and Concurrent Private Placement [Yahoo! Finance]

Citius Pharmaceuticals, Inc.  (CTXR) 
NASDAQ:AMEX Investor Relations: ir.citiuspharma.com
PDF oncology-focused subsidiary of Citius Pharmaceuticals, Inc. ("Citius Pharma") (Nasdaq: CTXR), a late-stage biopharmaceutical company developing and commercializing first [Read more]